Print  |  Font Size Change Font Size
Search naabt.org  

The National Alliance of Advocates
for Buprenorphine Treatment

Buprenorphine (Suboxone®, Subutex®) is an opioid medication used to treat opioid
addiction in the privacy of a physician's office.1 Buprenorphine can be dispensed
for take-home use, by prescription.1 This, in addition to the pharmacological and safety
profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.2

Donate

naabt sealWe welcome all donations. We have 501c(3) tax exempt status as a charitable organization. Donations made will become tax deductible retroactively in the year which the donation was made.

Paypal, credit cards

Donation Options

There are three options for making donations. The first is a recurring donation/subscription which can be made in any amount on a weekly, monthly or yearly basis. The second option is to make a one-time donation of any amount by clicking the "Paypal Donate" button below. The third is by mail.

1. Make a recurring donation:

Donation amount:
Frequency of donation: Weekly
Monthly
Yearly

 

2. One-time donation:

 

3. Mail donation:


NAABT,Inc.
P.O.Box 333
Farmington, CT 06034

 

Your contribution will be used for:

  • The continuing education and dissemination of information concerning opioid addiction treatment
  • Our mission to reduce the stigma and help connect patient to physician.

See about us for more details: http://www.naabt.org/about_us.cfm

 

National Drug & Alcohol Recovery MonthAddiction Survivors National Institute of HealthAlcohol AnswersNIDA
  1. U.S. Food and Drug Administration, FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence.
  2. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.